CEPI-U.S. for CEPI-U.S.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 11, 2021 | $35,000 | Replaced |
| 4th Quarter - Amendment | Mar 9, 2021 | $35,000 | Replaced |
| 4th Quarter - Amendment (this page) | Jan 25, 2022 | $40,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Education and advocacy supporting the mission of the Coalition for Epidemic Preparedness Innovations (CEPI), including development of vaccines for emerging diseases to help prevent and respond to epidemics and pandemics and strengthen global health security. H.R.2166 - Global Health Security Act of 2020 S.3829 - Global Health Security and Diplomacy Act of 2020 H.R.133: Consolidated Appropriations Act, 2021 [Including Coronavirus Stimulus & Relief]
Foreign entity interest: The Coalition for Epidemic Preparedness Innovations (CEPI) is based in Norway, and its mission is to promote the development and availability of vaccines against emerging epidemic and pandemic diseases. Lobbying efforts by CEPI-U.S. will support that mission.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RICHARD WILDER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.